Ulcerative Colitis Clinical Trials in Rochester, Minnesota

4 studies are recruiting for ulcerative colitis in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Site 028, Rochester, Minnesota
    Locations
    267 in total
    Run by
    Spyre Therapeutics, Inc.

    See if you can join NCT07012395 on ClinicalTrials.gov

  2. R-3750 in Patients With Mild to Moderate Ulcerative Colitis

    The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate ulcerative colitis. Patients will take an oral dosage of probiotic (R-3750) and provide patient-reported and physician scored measures of their colitis. Blood and …

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    5 in total
    Run by
    Rise Therapeutics LLC

    See if you can join NCT05666960 on ClinicalTrials.gov

  3. A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    The study is an extension of two parent studies (MLN0002-3024 [NCT04779307] and MLN0002-3025 [NCT04779320]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.

    Stage
    Phase 3
    Ages
    2 and older
    Site
    Mayo Clinic - PIN, Rochester, Minnesota
    Locations
    98 in total
    Run by
    Takeda

    See if you can join NCT05442567 on ClinicalTrials.gov

  4. Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

    Chronic intestinal hypoxia and accompanying mucosal inflammation is a hallmark of ulcerative colitis (UC). Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen under increased atmospheric pressure to increase tissue oxygenation. Two small prospective randomized controlled trials have dem…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    13 in total
    Run by
    Northwestern University

    See if you can join NCT05987852 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.